IL160412A0 - Methods and pharmaceutical compositions for immune deception, particularly in the treatment of cancer
- Google Patents
Methods and pharmaceutical compositions for immune deception, particularly in the treatment of cancer
Info
Publication number
IL160412A0
IL160412A0IL16041202AIL16041202AIL160412A0IL 160412 A0IL160412 A0IL 160412A0IL 16041202 AIL16041202 AIL 16041202AIL 16041202 AIL16041202 AIL 16041202AIL 160412 A0IL160412 A0IL 160412A0
Authority
IL
Israel
Prior art keywords
deception
immune
cancer
treatment
methods
Prior art date
Application number
IL16041202A
Original Assignee
Technion Res & Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Res & Dev FoundationfiledCriticalTechnion Res & Dev Foundation
Priority claimed from PCT/IL2002/000478external-prioritypatent/WO2002102299A2/en
Publication of IL160412A0publicationCriticalpatent/IL160412A0/en
Maytansinoid derivatives and pharmaceutical compositions containing the same, methods of producing the same and methods of use thereof for use in treating cancer
Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment